MetLife director Daniel S. Glaser acquires 544 shares

The award reflects stock-based payment of a portion of non-management director retainer fees, with receipt deferred under the directors' compensation plan.

Rhea-AI Filing Summary

MetLife Inc. director Daniel S. Glaser acquired 544 shares of common stock as compensation on October 1, 2026; the reported per-share amount was $94.35. The shares were part of director retainer fees paid in stock, and Glaser elected to defer their receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. After the award, he reported 3,249 directly held shares and 198 shares held indirectly in a GRAT.

Insider Trade Summary

Grant/Award: 544 shares

Grant/Award 2 txns

Insider Glaser Daniel S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	544	$94.35	$51K
holding	Common Stock F2	--	--	--

Holdings After Transaction: Common Stock — 3,249 shares (Direct); Common Stock — 198 shares (Indirect, By GRAT)

Footnotes (2)

1. F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
2. F2. These shares are held in a GRAT.

Key Figures

Shares acquired as award: 544 shares Reported per-share amount: $94.35 per share Direct shares following award: 3,249 shares +1 more

4 metrics

Shares acquired as award 544 shares October 1, 2026

Reported per-share amount $94.35 per share 544-share award on October 1, 2026

Direct shares following award 3,249 shares Reported after the October 1, 2026 award

Shares held in GRAT 198 shares Indirect holding reported on October 1, 2026

Key Terms

GRAT, Deferred Compensation Plan for Non-Management Directors, retainer fees

3 terms

GRAT financial

"These shares are held in a GRAT."

Deferred Compensation Plan for Non-Management Directors financial

"under the MetLife Deferred Compensation Plan for Non-Management Directors"

retainer fees financial

"a portion of non-management director retainer fees"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did MetLife director Daniel S. Glaser receive?

Daniel S. Glaser acquired an award of 544 shares of common stock on October 1, 2026. The shares were part of non-management director retainer fees paid in stock, and he elected to defer receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.

What per-share amount was reported for Daniel S. Glaser's MetLife award?

The transaction reported a per-share amount of $94.35 for the 544-share award. The shares were compensation under the non-management director retainer arrangements, and Glaser elected to defer receipt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 04:04 PM Accepted by SEC EDGAR 10/05/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glaser Daniel S

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2026		A(1)		544	A	$94.35	3,249	D
Common Stock								198(2)	I	By GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

2. These shares are held in a GRAT.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)